Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (300K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Gaudet, P.
Right arrow Articles by Tsang, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaudet, P.
Right arrow Articles by Tsang, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Regulation of the ribonucleotide reductase small subunit gene by DNA-damaging agents in Dictyostelium discoideum
Nucleic Acids Research Pages 3042-3048


Regulation of the ribonucleotide reductase small subunit gene by DNA-damaging agents in Dictyostelium discoideum
Introduction
Materials And Methods
   Growth, development and transformation of Dictyostelium cells
   Generation of deletions
   Drug treatments and cell survival
   RNA preparation and hybridization
Results
   DNA-damaging agents stimulate the accumulation of rnrB transcript
   Hydroxyurea has little effect on rnrB expression
   Up-regulation of rnrB is rapid, transient and independent of protein synthesis
   Effect of DNA-damaging agents on rnrB is independent of developmental stage
   Identification of cis-acting elements controlling the DNA damage response
Discussion
Acknowledgements
References


Regulation of the ribonucleotide reductase small subunit gene by DNA-damaging agents in Dictyostelium discoideum

Pascale Gaudet1, 2, Adrian Tsang1, 2, 3, *

1Department of Chemistry and Biochemistry, 2Centre for Structural and Functional Genomics and 3Department of Biology, Concordia University, 1455 de Maisonneuve Boulevard W., Montreal, Quebec H3G 1M8, Canada

Received April 26, 1999; Revised and Accepted June 21, 1999

ABSTRACT

In Escherichia coli, yeast and mammalian cells, the genes encoding ribonucleotide reductase, an essential enzyme for de novo DNA synthesis, are up-regulated in response to DNA damaging agents. We have examined the response of the rnrB gene, encoding the small subunit of ribonucleotide reductase in Dictyostelium discoideum, to DNA damaging agents. We show here that the accumulation of rnrB transcript is increased in response to methyl methane sulfonate, 4-nitroquinoline-1-oxide and irradiation with UV-light, but not to the ribonucleotide reductase inhibitor hydroxyurea. This response is rapid, transient and independent of protein synthesis. Moreover, cells from different developmental stages are able to respond to the drug in a similar fashion, regardless of the basal level of expression of the rnrB gene. We have defined the cis-acting elements of the rnrB promoter required for the response to methyl methane sulfonate and 4-nitroquinoline-1-oxide by deletion analysis. Our results indicate that there is one element, named box C, that can confer response to both drugs. Two other boxes, box A and box D, specifically conferred response to methyl methane sulfonate and 4-nitroquinoline-1-oxide, respectively.

INTRODUCTION

Activation of specific genes is a primary response of cells to damaged DNA. The physiological role of this response and its underlying mechanism are reasonably well understood in bacteria. However in eukaryotes these processes are not clearly defined. In yeast the genes activated by DNA-damaging agents include those involved in nucleotide excision repair, post-replication repair and double-stand break repair. Also induced by DNA-damaging agents are some of the genes which play a dual role in nucleic acid metabolism and DNA repair; for example, the genes encoding DNA ligase I, DNA polymerase I and ribonucleotide reductase (1). The activation of these genes is thought to be needed to fuel DNA synthesis during repair. The response to DNA-damaging agents in mammalian cells is complex and involves many genes and proteins in addition to those implicated in DNA repair and its related processes (2). The reason for such diverse responses is not clear but presumably reflects the requirement for coordination of regulated responses between cells in a multicellular organism.

The enzyme ribonucleotide reductase catalyzes the first reaction in dNTPs synthesis, the conversion of ribonucleotides into deoxyribonucleotides. Because of its essential role in DNA synthesis, this enzyme is expected to play an important part in the repair of damaged DNA. An increase in the number of chromosome aberrations was observed when irradiated human lymphoblastoid cells were incubated with inhibitors of ribonucleotide reductase (3-5). In addition, ribonucleotide reductase has been implicated in carcinogenesis. In the presence of activated oncogenes, overexpression of the small subunit of ribonucleotide reductase has been shown to affect the rates of tumor formation and metastasis in mice (6,7). For these reasons ribonucleotide reductase is a key target for drug design in cancer therapy (8). In bacteria, yeast and mammalian cells the ribonucleotide reductase genes are inducible by DNA-damaging agents (9). That induction of ribonucleotide reductase by DNA-damaging agents is observed in all species studied underscores the importance of this response. Despite its relevance in DNA repair and in tumorigenesis, the mechanism mediating the response of the ribonucleotide reductase genes to DNA-damaging agents is not fully understood.

Many of the genes activated by DNA-damaging agents are also under cell-cycle control. Thus analysis of the effects of DNA-damaging agents in proliferating cells may be complicated by mechanisms that overlap the repair and growth processes. Growth and development are mutually exclusive events in Dictyostelium discoideum. Processes operating during growth are down-regulated during development. Hence the developmental phase of Dictyostelium offers a convenient system to study the effects of DNA-damaging agents on gene expression in the absence of cell growth. We have previously isolated the gene encoding the small subunit of ribonucleotide reductase in Dictyostelium, rnrB (10). Here we show that the expression of rnrB is inducible by DNA-damaging agents during growth and at different stages of development. We have also identified the cis-acting elements of rnrB involved in the response to DNA-damaging agents.

MATERIALS AND METHODS

Growth, development and transformation of Dictyostelium cells

Cells of strain AX2 were grown axenically in HL5 medium (11). The cells were harvested at 2-4 × 106 cells/ml, washed with KKP buffer (20 mM KH2PO4/K2HPO4, pH 6.2) and developed in KKP buffer at 107 cells/ml with shaking, or on polycarbonate filters as described (12). Dictyostelium cells were transformed by calcium phosphate coprecipitation (13). Transformants were selected in HL5 medium containing 20 µg/ml of G418 (Gibco). Pools of at least 50 transformants were used for analysis to minimize the variation due to integration site and/or copy number (14).

Generation of deletions

The plasmid pDdrnrB/lacZ contains half of the coding region from capA (15), two-thirds of the coding region of rnrB fused in frame to lacZ, and the complete intergenic region located between them (10). Construction and sequencing of the 5[prime] deletions were described previously (16). The constructs are referred to by the number of bases remaining between the site of the deletion and the A of the first ATG codon.

Internal deletions were constructed using two different PCR products of the rnrB promoter. The 5[prime] primer for both products was 5[prime]-TTACTAGTGAAATACCTGCACCTCC-3[prime] (underlined base corresponds to a mismatch in the primer to its complementary sequence). This primer is located from base -1779 to base -1755 with respect to the A of the first ATG of rnrB. It contains an added SpeI site to allow cloning in the XbaI site of the deletion constructs. The sequences of the two 3[prime] primers are as follows: box B primer (Fig. 5): 5[prime]-TTGAATTCAAAATAC-ACACACATTCCCG-3[prime], and box C primer (Fig. 5): 5[prime]-TT-GAATTCATGATGGAATCACCGTTCC-3[prime]. The engineered EcoRI sites in these primers, as shown by the underlined bases, were used for cloning in the deletion constructs. Polymerase chain reactions were performed with ExpandTM (Boehringer Mannheim) according to the manufacturer's instructions, using an annealing temperature of 55°C. The internal deletions are designated -X[Delta]-Y, where X and Y indicate the nucleotides 5[prime] and 3[prime] from the deleted regions, respectively. All internal deletions retain the EcoRI site from the polylinker of the vector. Deletions -429[Delta]-340, -429[Delta]-280 and -429[Delta]-212 were constructed using the PCR product generated with the 3[prime] box C primer, digested with SpeI and KpnI, and inserted into the XbaI and KpnI sites of the 5[prime] deletion constructs [Delta]-340, [Delta]-280 and [Delta]-212, respectively. Deletions -444[Delta]-311, -444[Delta]-280 and -444[Delta]-212 were obtained by inserting the SpeI/XbaI fragment of the above PCR product into the XbaI site of [Delta]-311, [Delta]-280 and [Delta]-212, respectively. Deletions -359[Delta]-280 and -359[Delta]-212 were produced with the same PCR fragment digested with SpeI and EcoRI and cloned into the XbaI and EcoRI sites of constructs [Delta]-280 and [Delta]-212, respectively. Finally, deletion -292[Delta]-212 was constructed with the PCR product obtained with the 3[prime] box B primer, digested with SpeI and EcoRI, and inserted into the XbaI and EcoRI sites of the deletion construct [Delta]-212.

Drug treatments and cell survival

For treatment of vegetative cells, stock solutions of the drugs were added directly to growing cells in HL5 medium. For treatment with chemical agents during early development, the cells were developed in suspensions of KKP for 4 h prior to the addition of drug solutions. Cells irradiated with UV and cells treated with genotoxic agents during late development were developed on filters saturated with KKP at 106 cells/cm2. For treatment with chemical agents the filters were placed for 1 h on pads of blotting paper that had been saturated with KKP containing drugs at the specified concentrations. Irradiation with UV was performed using an UV cross-linker (Stratalinker 1800, Stratagene). The UV source was calibrated with uridylic acid as a chemical actinometer (17) correcting for absorption by the solution (18). Methyl methane sulfonate (MMS), 4-nitroquinoline-1-oxide (4NQO) and cycloheximide were purchased from Sigma. Hydroxyurea was obtained from ICN.

Following treatment with genotoxic agents, the cells were diluted in KKP. Aliquots of the various dilutions were spread together with Enterobacter aerogenes on SM plates (19). Survivors were scored by counting the number of plaques on the SM plates.

RNA preparation and hybridization

Cells were collected by centrifugation and washed once with cold KKP buffer. The cell pellets were frozen on dry ice and kept at -70°C until the RNA was extracted. Total RNA was isolated according to the protocol by Franke et al. (20) in microfuge tubes using 2 × 107 cells.

For northern blot analysis, 10 µg of RNA were mixed with ethidium bromide and resolved on formaldehyde gels as described (21). After electrophoresis, the gels were visualized under a UV illuminator to ensure even loading. Nucleic acids were transferred onto Nytran membranes (Schleicher & Schuell) in 10× SSC and cross-linked using a UV cross-linker. Radioactive probes were generated by random priming following the manufacturer's protocol (Pharmacia) with [[alpha]-32P]-dCTP (ICN). The rnrB probe was the EcoRI-DraI fragment of the rnrB coding sequence, a region not present in the reporter construct (10). Hybridizations were conducted according to standard protocols in Denhardt's hybridization solution with 50% formamide (22). Hybridizations and stringency washes were performed as follows: for the rnrB and pB47 probes, the blots were hybridized at 40°C overnight and washed twice for 30 min in 1× SSC, 0.1% SDS at 65°C; for the lacZ and the capA probes, hybridization temperature was 45°C and the washes were done in 0.1× SSC, 0.1% SDS at 65°C. Blots were exposed to Kodak X-Omat films with intensifying screens. For each experiment, the same blot was hybridized with different probes. Between each hybridization, the probe was stripped from the membrane by incubating twice for 15 min in a boiling solution of 0.1× SSPE and 0.5% SDS.

For dot blot analysis, 10 µg of total RNA were treated with 0.3 U of RQ1 RNase-free DNase (Promega) for 30 min at 37°C. This suspension was mixed with 3 vol of denaturation solution (37% formaldehyde, 100% formamide and 20× SSC, in a 7:20:2 ratio), heated at 65°C for 15 min, and chilled on ice. Two volumes of 20× SSC were then added to the solution. The RNA samples were spotted in duplicate (5 µg per spot) onto Nytran membranes that had been washed with 10× SSC. The membrane was washed again with 10× SSC and finally the nucleic acids were cross-linked.

To determine the level of expression of the reporter transcript, dot blots were quantified using a PhosphorImager (BioRad GS-363) and the signal intensities were determined using Molecular AnalystTM software (BioRad). The fold-induction of rnrB was determined by dividing rnrB transcript level in treated cells by that of untreated cells. On average, induction for MMS and 4NQO was 7.5- and 15-fold, respectively. To compensate for variations among experiments, a correction factor was used to calculate the fold induction for the reporter gene activity. The correction factor was obtained by dividing the average induction level for rnrB by that of the observed induction level. Thus, if the observed induction for 4NQO was 30-fold, the correction factor would be 15/30 or 0.5. The fold-induction of the reporter transcript was calculated by dividing the level of lacZ message in treated cells by that of the untreated cells, then multiplying this value by the correction factor.

RESULTS

DNA-damaging agents stimulate the accumulation of rnrB transcript

We examined the effects of the UV-mimetic agent 4NQO, the alkylating agent MMS and UV irradiation on the expression of the mrB gene in Dictyostelium. As shown in Figure 1, the level of rnrB transcript increased when 4 h-developing cells were exposed to DNA-damaging agents. The increase in the accumulation of rnrB transcript in response to DNA-damaging agents was dose-dependent. The levels of induction elicited by 10 µg/ml of 4NQO, 15 mM of MMS and 30 J/m2 UV-irradiation were ~15-, 7.5- and 15-fold, respectively. The survival rates for 5, 10, 15 and 20 mM of MMS were 99, 70, 30 and <1%, respectively. In the case of 4NQO the survival rates for 1, 5 and 10 µg/ml were 99, 50 and 2%, respectively. Over 95% of the cells survived a dose of 30 J/m2 of UV irradiation. These values are consistent with the data published previously (23,24).


Figure 1. Effect of DNA-damaging agents on the accumulation of the rnrB transcript. AX2 cells were developed for 4 h and exposed for 1 h to 4NQO (1, 5 or 10 µg/ml), to MMS (5, 10, 15 or 20 mM) or to hydroxyurea (3, 10, 30 or 100 mM). For UV treatment 4 h cells were irradiated at 1, 5 or 30 J/m2, then incubated on pads saturated with KKP for 1 h. Total cellular RNA was extracted, resolved by denaturing electrophoresis, and blotted onto membranes. Autoradiographs obtained from probing the same membrane for the rnrB gene and the capA gene are shown. C represents the untreated control.

To ensure that the induction of rnrB by DNA-damaging agents is a specific event we investigated the accumulation of capA transcripts (25). The capA gene is located upstream of rnrB and is transcribed in the opposite orientation in relation to rnrB (10). Unlike rnrB, the capA gene is constitutively expressed during growth and throughout development (25). Figure 1 shows that the levels of the two capA transcripts, generated by alternative splicing of a retained intron (25), remained relatively unchanged in the presence of various DNA-damaging agents. The expression of the gene encoding calmodulin is also not affected by DNA-damaging agents (data not shown).

Hydroxyurea has little effect on rnrB expression

We tested the effect of the ribonucleotide reductase inhibitor hydroxyurea on the level of rnrB transcript. Figure 1 shows that the presence of hydroxyurea has only a very modest effect on the expression of rnrB. The expression of the capA gene was not affected by these treatments. The doses we used, ranging from 3 to 100 mM, are known to have dramatic effects on the growth of Dictyostelium cells (26).

Up-regulation of rnrB is rapid, transient and independent of protein synthesis

We determined the rate of accumulation of the rnrB transcript in response to DNA-damaging agents. Figure 2 shows the accumulation of rnrB transcript in the continuous presence of 5 µg/ml of 4NQO. The increase in rnrB transcript level was detectable as early as 10 min after the beginning of treatment. The up-regulation of the rnrB transcript level was transient, reaching the peak level of accumulation after 60 min of treatment.


Figure 2. Time course of increase of rnrB transcript level in response to 4NQO. AX2 cells were developed for 4 h and exposed to 5 µg/ml of 4NQO. Total RNA was extracted from cells before the addition of the drug (0) and from cells that had been incubated for 5, 10, 20, 30, 60, 90, 120 and 180 min with the drug. Shown here is an autoradiograph of a northern blot probed for rnrB expression.

The rapid response suggested that the up-regulation of the rnrB message by DNA-damaging agents involves pre-existing factors. To gain further support for this assertion we investigated the induction process in the presence of the protein synthesis inhibitor cycloheximide. Figure 3 shows the effects of 4NQO on gene expression in the presence of cycloheximide. Prior treatment with cycloheximide did not alter appreciably the 4NQO-stimulated increase in the accumulation of the rnrB transcript. We tested the effectiveness of the cycloheximide treatment by examining the expression of a gene we serendipitously found to be stimulated by protein synthesis inhibitors. Partial sequence analysis revealed that the clone pB47 encodes a homolog of seryl-tRNA synthase (unpublished data). Cycloheximide, but not 4NQO, stimulated an increased accumulation of the pB47 transcript. Also shown in Figure 3 are the levels of the capA transcripts, which remained relatively unaffected by either of the drug treatments. These results indicate that the induction of rnrB by DNA-damaging agents can take place in the presence of a protein synthesis inhibitor.


Figure 3. Effect of 4NQO and cycloheximide on the accumulation of the rnrB transcript. AX2 cells which had been developed for 4 h were exposed to either 500 µg/ml cycloheximide, 10 µg/ml 4NQO or to both for 1 h. When both drugs were given, cycloheximide was added 10 min before 4NQO. Shown here are autoradiographs of the same membrane probed with rnrB, pB47 and capA. + indicates the presence and - shows the absence of the drugs.

Effect of DNA-damaging agents on rnrB is independent of developmental stage

When deprived of nutrient Dictyostelium cells embark upon a program of development and differentiation. A 24 h developmental program transforms the cells into fruiting bodies composed of two main cell types, spores and stalk cells. The rate of DNA synthesis decreases as the cells enter development. Interestingly there is another round of DNA synthesis shortly after the cells have undergone aggregation, at ~12 h of development (27-31). Coincident with the increase in the rate of DNA synthesis is the expression of rnrB. The level of rnrB transcript is moderate in growing cells, low in the first 10 h of development and high during late development (10). To evaluate the process of DNA damage induction under different physiological conditions we treated vegetatively growing cells, 4- and 15 h-developing cells with 4NQO. Figure 4 shows that at these three stages of the life cycle, the cells were capable of responding to 4NQO in the induction of rnrB. A similar effect was observed when the cells were treated with MMS or UV irradiation (data not shown). Moreover the level of induction was very similar for vegetative cells and for cells from different stages of development. At 10 µg/ml of 4NQO, the level of induction was ~15-fold for all three stages of the life cycle.


Figure 4. Regulation of rnrB by DNA-damaging agents during growth and development. Growing cells and cells which had been developed for different lengths of time were treated with 1, 5 or 10 µg/ml of 4NQO for 1 h at the times indicated. Total RNA was extracted and analyzed by northern blot. Autoradiographs of the same membrane probed with rnrB and capA are shown. C, untreated control.


Figure 5. Transcriptional response directed by the deletion constructs in the presence of DNA-damaging agents. Cells were developed for 4 h and treated with 10 µg/ml of 4NQO or 25 mM of MMS for 1 h. Total RNA was extracted and analyzed by dot blot. The induction values correspond to the increase in the lacZ transcript level after correction for the endogenous rnrB induction as described in the Materials and Methods section. Each value is the average of two independent experiments ±standard deviation. A construct was judged damage-inducible (+) if the level of the lacZ transcript was at least 2-fold higher than that in untreated cells. Undetectable means that the signal for the lacZ transcript was too close to that of the background to be quantified accurately.

We also investigated the expression of the capA gene and found that the levels of the capA transcripts varied only slightly. The variations observed did not correlate with either the drug or the dosage used.

Identification of cis-acting elements controlling the DNA damage response

Similar to other Dictyostelium promoters, the 5[prime] untranscribed region of the rnrB gene contains >85% A and T residues with clusters of G/C-rich sequences of ~15-20 bp in length. In several Dictyostelium promoters that have been analyzed previously, G/C boxes have been shown to be important for control of gene expression (32,33). The location of the four G/C-rich boxes that are closest to the rnrB transcription start site is indicated in Figure 5. We refer to these sequences as elements A, B, C and D, from the most proximal to the transcription start site to the most distal, respectively. Table 1 shows the sequence of each of these elements.

Table 1. Sequence of the four GC-rich boxes most proximal to the rnrB start site
Box Position Sequence
A -237 to -222 5[prime]-GGACCAAAATTGCGC-3[prime]
B -313 to -299 5[prime]-CGGAATGTGTGTG-3[prime]
C -378 to -362 5[prime]-GGAACGGTGATTCCATC-3[prime]
D -450 to -430 5[prime]-TCTAGAATCGGAGTGGTACC-3[prime]

We used promoter deletion analysis to define the cis-acting elements of the rnrB promoter involved in the response to DNA-damaging agents. A schematic representation of the constructs used in this study is shown in Figure 5. Dictyostelium cells carrying the deletion constructs were developed for 4 h and exposed for 1 h to either 10 µg/ml of 4NQO or 25 mM MMS. The fold-increase in lacZ transcript level for each construct in the presence of MMS or 4NQO is shown in Figure 5. Deletion of the upstream region of the rnrB promoter up to base -450 did not affect the up-regulation of the gene following treatment with 4NQO or MMS. In addition, cells bearing the internal deletion construct -444[Delta]-212, missing the four G/C-rich boxes A-D, failed to respond to either drug. Together these results suggest that the sequence between -444 and -212 contains the elements necessary for the DNA-damage induction of rnrB.

A 5[prime] deletion construct missing all the sequence upstream of base -311 rendered the reporter construct unresponsive to 4NQO. Similarly, all constructs missing additional sequence were unable to respond to 4NQO. Therefore in this sequence context, the 94-bp region comprised between -405 and -311 and containing the G/C-rich box C is essential to confer 4NQO-induced DNA damage response. Results from experiments conducted with internal deletions constructs showed that the presence of box D could restore the response to 4NQO (compare constructs -444[Delta]-212 and -429[Delta]-212). This suggests that in addition to box C, box D also plays a role in the response to 4NQO. Consistent with the results from the 5[prime] deletions an internal deletion construct bearing box A alone, construct -444[Delta]-280, was ineffective in promoting 4NQO response on the reporter construct. Construct -444[Delta]-311, containing both box A and box B, showed a response to 4NQO, which contradicted the results obtained with the 5[prime] deletion constructs. Because this region was unable to confer response to 4NQO in the context of 5[prime] deletion constructs, we concluded that boxes C and D are the major elements involved in the response to 4NQO.

When treated with MMS, the transcript encoded by the 5[prime] deletion construct [Delta]-280 was up-regulated. The only G/C-rich element present in this construct is box A. Constructs with further truncation, [Delta]-225, [Delta]-212 and [Delta]-130, were unresponsive to MMS. Therefore it appears that box A is sufficient for the up-regulation of rnrB by MMS. The results obtained using the strains bearing the internal deletion constructs are consistent with this idea. The internal deletion -444[Delta]-280 (with boxes B-D missing) responded to MMS whereas construct -444[Delta]-212 (missing boxes A-D) and -429[Delta]-212 (containing box D alone) did not. However the deletion construct -359[Delta]-212 containing boxes C and D was inducible by MMS. These results suggest that box C can confer induction by MMS. From these results we conclude that box A and box C are involved in the response to the alkylating agent MMS.

DISCUSSION

In mammalian cells and yeast, the level of expression of a large number of genes increases in response to DNA-damaging agents. Many of these responsive genes are normally required for repair and synthesis of DNA (1). In Dictyostelium, the genes encoding apurinic/apyrimidic endonuclease and the helicases repB and repD (repB and repD are homologs of the xeroderma pigmentosum XPB and XPD genes, respectively) have recently been shown to be up-regulated by DNA-damaging agents (34,35). We showed here that the transcript level of the small subunit of ribonucleotide reductase increased when Dictyostelium cells were treated with 4NQO, MMS or UV irradiation. These results suggest that, as in other organisms, DNA-damaging agents induce the expression of specific Dictyostelium genes involved in DNA repair and metabolism.

The mechanisms mediating the effects of DNA-damaging agents share common features. In yeast, the up-regulation of ribonucleotide reductase by DNA-damaging agents is mediated by pre-existing factors that do not require protein synthesis to become activated (36). The expression of the apurinic/apyrimidic endonuclease gene from Dictyostelium has also been shown to be DNA damage-inducible in a protein-synthesis independent fashion (34). Our results with the protein synthesis inhibitor cycloheximide strongly suggest that the up-regulation of the rnrB transcript upon treatment with DNA-damaging agents takes place via a similar mechanism. Furthermore, the demonstration by deletion analysis that specific promoter regions are necessary for the induction by DNA-damaging agents suggests that an increase in transcriptional rate of the rnrB gene is an important part of the response.

In Dictyostelium, the up-regulation of gene activity in response to DNA-damaging agents is transient. Besides rnrB, this has been shown to be the case for the apurinic/apyrimidic endonuclease gene as well as the repB and repD genes (34,35). The drop in transcript level after prolonged treatment observed for these genes is possibly caused by cell death and/or breakdown of the drugs. In yeast the induction of a number of DNA damage-responsive genes has also been shown to be transient, including RNR2, POL1, RAD6, RAD7, RAD18, RAD23 and RAD51 (36-42).

The level of rnrB expression fluctuates during the life cycle of Dictyostelium. Regardless of the endogenous rnrB level, the same magnitude of induction by DNA-damaging agents was observed at different stages of development and during growth. This suggests that the factors involved in the response to DNA-damaging agents are present at all stages of the life cycle. It also implies that the mechanisms mediating the effects of DNA-damaging agents on rnrB operate independently from processes which regulate the expression of rnrB during growth and development. In support of this finding, the repB and repD genes have been shown to be induced by DNA-damaging agents at different stages of the Dictyostelium life cycle (35).

Hydroxyurea is a specific inhibitor of ribonucleotide reductase. It inactivates the tyrosyl free radical of the small subunit that is required for enzyme activity. Overexpression of the small subunit is sufficient to confer resistance to hydroxyurea in mammalian cell lines (43). The presence of hydroxyurea leads to the depletion of nucleotides, and consequently blocks DNA synthesis. The inhibition of DNA synthesis by hydroxyurea can be reversed by addition of nucleotides (reviewed in 44). Hydroxyurea causes an increase in RNR2 transcript level in yeast (36,45-47). In response to hydroxyurea mammalian cells increase the rate of synthesis and the stability of both subunits of ribonucleotide reductase (48) but do not alter the levels of their transcripts (49). As in mammalian cells, hydroxyurea does not stimulate the accumulation of rnrB transcript in Dictyostelium. However, we do not know if hydroxyurea has an effect on the post-transcriptional regulation of ribonucleotide reductase in Dictyostelium.

To our knowledge, this is the first report that shows the involvement of different cis-regulatory elements in the response to different DNA-damaging agents. We observed that the cis-regulatory element box C was able to confer transcriptional response to both MMS and 4NQO. We also showed that box A mediated the response to MMS whereas box D promoted the response to 4NQO. The reason for the involvement of different cis-regulatory elements is not clear. These two drugs have different modes of action, MMS induces alkylation of DNA while 4NQO generates bulky adducts (1). The damage caused by these two drugs could activate a different, yet overlapping, set of transcription factors. Another possibility is that the damaged DNA is not the only cause of the response. MMS can generate alkylation damage to cellular components other than DNA damage, and 4NQO and UV are known to cause oxidative stress. These other types of damage could trigger signal transduction cascades that result in the expression of the rnrB gene in addition to the DNA damage signal.

The results obtained from promoter analysis are complex, especially those involving internal deletions. There are several reasons for some of the inconsistencies observed. Spacing between regulatory elements may influence the level of expression. For example, the internal deletion construct containing both box A and box B (-444[Delta]-311) was induced to a higher level than the construct containing only box A (-444[Delta]-280). But in the 5[prime] deletions, the construct containing both box A and box B ([Delta]-311) exhibited a similar level of induction as the construct containing box A alone ([Delta]-280). Moreover, the transcript produced by the lacZ reporter is unstable (50,51; unpublished data). The latter observation may in part explain why the level of induction for lacZ is lower than that of the endogenous rnrB (Fig. 5).

Dictyostelium is highly resistant to radiation. Doses of UV light causing 90% killing range from 150 to 200 J/m2 (23,52). In mammalian cells and yeast, a similar level of cell death is obtained with 30 J/m2 (53-57). There is growing evidence that survival to genotoxic stresses in mammalian cells is determined by the ability to repair essential genes rather than to perform genome-wide repair (56-59). In Dictyostelium, there is indication of two different pathways for repairing UV-induced DNA lesions, one transcription-dependent and one transcription-independent system (60,61). This might explain the unusual resistance of this organism to radiation. We show here that irradiation with UV strongly stimulates rnrB expression. A dose of 30 J/m2 caused a 15-fold increase in the accumulation of rnrB transcript. In yeast, a similar dose elicits a 2-4-fold increase (36,45). Therefore, the high degree of resistance to UV in Dictyostelium cells might result from increased availability of dNTPs for repair. The high level of rnrB expression might enhance the repair capability of Dictyostelium cells to UV irradiation.

ACKNOWLEDGEMENTS

We wish to thank Claire Bonfils for technical assistance and discussion. This work was supported by NSERC of Canada. P.G. is a recipient of a NSERC postgraduate scholarship.

REFERENCES

1. Friedberg, E.C, Walker,G.C. and Siede,W. (1995) DNA Repair and Mutagenesis. ASM Press, Washington, DC.

2. Bender, K., Blattner,C., Knebel,A., Iordanov,M., Herrlich,P. and Rahmsdorf,H.J. (1997) J. Photochem. Photobiol., 37, 1-17.

3. Antoccia, A., Palitti,F., Raggi,T., Catena,C. and Tanzarella,C. (1994) Int. J. Radiat. Biol., 66, 309-317. MEDLINE Abstract

4. Collins, A. and Oates,D.J. (1987) Eur. J. Biochem., 169, 299-305. MEDLINE Abstract

5. Hinglso, J.K., Brunborg,G., Steffensen,I.L. and Holme,J.A. (1993) Mutagenesis, 8, 423-429. MEDLINE Abstract

6. Fan, H., Villegas,C. and Wright,J.A. (1996) Proc. Natl Acad. Sci. USA, 93, 14036-14040. MEDLINE Abstract

7. Fan, H., Huang,A., Villegas,C. and Wright,J.A. (1997) Proc. Natl Acad. Sci. USA, 94, 13181-13186. MEDLINE Abstract

8. Szekeres, T., Friezer-Szekeres,M. and Elford,H.L. (1997) Crit. Rev. Clin. Lab. Sci., 34, 503-528. MEDLINE Abstract

9. Elledge, S.J., Zhou,Z., Allen,J.B. and Navas,T.A. (1993) Bioessays, 15, 333-339. MEDLINE Abstract

10. Tsang, A., Bonfils,C., Czaika,G., Shtevi,A. and Grant,C. (1996) Biochim. Biophys. Acta, 1309, 100-108. MEDLINE Abstract

11. Watts, D.J. and Ashworth,J.M. (1970) Biochem. J., 119, 171-174. MEDLINE Abstract

12. Bonfils, C., Greenwood,M. and Tsang,A. (1994) Mol. Cell. Biochem., 139, 159-166.

13. Early, A. and Williams,J.G. (1987) Gene, 59, 99-106. MEDLINE Abstract

14. Early, A.E., Gaskell,M.J., Traynor,D. and Williams,J.G. (1993) Development, 118, 353-362. MEDLINE Abstract

15. Grant, C.E. and Tsang,A. (1990) Gene, 96, 213-218. MEDLINE Abstract

16. Bonfils, C., Gaudet,P. and Tsang,A. (1999) J. Biol. Chem., 274, in press. MEDLINE Abstract

17. Smith, K.C. (1977) In Smith,K.C. (ed.), The Science of Photobiology. Plenum Press, NY, pp. 113-142.

18. Morowitz, H.J. (1950) Science, 111, 229-230.

19. Sussman, M. (1966) In Prescott,D. (ed.), Methods of Cell Physiology. Academic Press, NY, Vol 2, pp. 397-410.

20. Franke, J., Podgorski,G.J. and Kessin,R.H. (1987) Dev. Biol., 124, 504-511. MEDLINE Abstract

21. Fourney, R.M., Miyakoshi,J., Day,R.S.,III and Paterson,M.S. (1988) Focus, 10, 5-6.

22. Sambrook, J., Fritsch,E.F. and Maniatis,T. (1989) (eds), Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.

23. Brooner, C.E., Welker,D.L. and Deering,R.A. (1992) Mutat. Res., 274, 187-200. MEDLINE Abstract

24. Payez, J.F., Deering,R.A. and Freim,J.O.,Jr (1972) Mutat. Res., 15, 82-85.

25. Grant, C.E., Bain,G. and Tsang,A. (1990) Nucleic Acids Res., 18, 5457-5463. MEDLINE Abstract

26. Deering, R.A. and Michrina,C.A. (1982) Antimicrob. Agents. Chemother., 21, 764-769. MEDLINE Abstract

27. Zimmerman, W. and Weijer,C.J. (1993) Dev. Biol., 160, 178-185. MEDLINE Abstract

28. Durston, A.J. and Vork,F. (1978) Exp. Cell Res., 115, 454-457. MEDLINE Abstract

29. Zada-Hames, I.M. and Ashworth,J.M. (1978) Dev. Biol., 63, 307-320. MEDLINE Abstract

30. Shaulsky, G. and Loomis,W.F. (1995) Proc. Natl Acad. Sci. USA, 92, 5660-5663. MEDLINE Abstract

31. Deering, R.A. (1982) J. Gen. Microbiol., 128, 2439-2447. MEDLINE Abstract

32. Haberstroh, L., Galindo,J. and Firtel,R.A. (1991) Development, 113, 947-958. MEDLINE Abstract

33. Pears, C.J. and Williams,J.G. (1987) EMBO J., 6, 195-200.

34. Freeland, T.M., Guyer,R.B., Ling,A.Z. and Deering,R.A. (1996) Nucleic Acids Res., 24, 1950-1953. MEDLINE Abstract

35. Yu, S.-L., Lee,S.-K., Alexander,H. and Alexander,S. (1998) Nucleic Acids Res., 26, 3397-3403. MEDLINE Abstract

36. Elledge, S.J. and Davis,R.W. (1989) Mol. Cell. Biol., 9, 4932-4940. MEDLINE Abstract

37. Johnston, L.H., White,J.H.M., Johnson,A.L., Lucchini,G. and Plevani,P. (1987) Nucleic Acids Res., 15, 5017-5030. MEDLINE Abstract

38. Madura, K., Prakash,S. and Prakash,L. (1990) Nucleic Acids Res., 18, 771-778. MEDLINE Abstract

39. Jones, J.S., Prakash,L. and Prakash,S. (1990) Nucleic Acids Res., 18, 3281-3285. MEDLINE Abstract

40. Jones, J.S. and Prakash,L. (1991) Nucleic Acids Res., 19, 893-898. MEDLINE Abstract

41. Madura, K. and Prakash,S. (1990) Nucleic Acids Res., 18, 4737-4742. MEDLINE Abstract

42. Shinohara, A., Ogawa,H. and Ogawa,T. (1992) Cell, 69, 457-470. MEDLINE Abstract

43. Zhou, B.-S., Hsu,N.-Y., Pan,B.-C., Doroshow,J.H. and Yen,Y. (1995) Cancer Res., 55, 1328-1333. MEDLINE Abstract

44. Reichard, P. (1988) Annu. Rev. Biochem., 57, 349-374. MEDLINE Abstract

45. Hurd, H.K. and Roberts,J.W. (1989) Mol. Cell. Biol., 9, 5359-5372. MEDLINE Abstract

46. Elledge, S.J. and Davis,R.W. (1990) Genes Dev., 4, 740-751. MEDLINE Abstract

47. Huang, M. and Elledge,S.J. (1997) Mol. Cell. Biol.,17, 6105-6113. MEDLINE Abstract

48. McClarty, G.A., Chan,A.K., Choy,B.K., Thelander,L. and Wright,J.A. (1988) Biochemistry, 27, 7524-7531. MEDLINE Abstract

49. Filatov, D., Bjorklund,S., Johansson,E. and Thelander,L. (1996) J. Biol. Chem., 271, 23698-23704. MEDLINE Abstract

50. Barklis, E., Pontius,B., Barfield,K. and Lodish,H.F. (1985) Mol. Cell. Biol., 5, 1465-1472. MEDLINE Abstract

51. Esch, R.K. and Firtel,R.A. (1991) Gen. Dev., 5, 9-21.

52. Welker, D.L. and Deering,R.A. (1978) J. Gen. Microbiol., 109, 11-23.

53. Johnston, L.H. and Johnson,A.L. (1995) Nucleic Acids Res., 23, 2147-2152. MEDLINE Abstract

54. Sebastian, J., Kraus,B. and Sancar,G.B. (1990) Mol. Cell. Biol., 10, 4630-4637. MEDLINE Abstract

55. Akiyama, N., Alexander,D., Aoki,Y. and Noda,M. (1996) Mutat. Res., 372, 119-131. MEDLINE Abstract

56. Cleaver, J.E., Charles,W.C., McDowell,M.L., Sadinski,W.J. and Mitchell,D.L. (1995) Cancer Res., 55, 6152-6160. MEDLINE Abstract

57. Bohr, V.A., Okumoto,D.S. and Hanawalt,P.C. (1986) Proc. Natl Acad. Sci. USA, 83, 3830-3833. MEDLINE Abstract

58. Petersen, L.N., Stevnsner,T. and Bohr,V.A. (1995) Carcinogenesis, 16, 3075-3081. MEDLINE Abstract

59. Lommel, L. and Hanawalt,P.C. (1993) Mol. Biol. Cell, 13, 970-976.

60. Maudlin, S.K., Freeland,T.M. and Deering,R.A. (1994) Mutat. Res., 314, 187-198. MEDLINE Abstract

61. Welker, D.L. and Deering,R.A. (1979) Mol. Gen. Genet., 167, 265-270. MEDLINE Abstract


*To whom correspondence should be addressed. Tel: +1 514 848 3405; Fax: +1 514 848 2881; Email: tsang{at}vax2.concordia.ca


This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals
Comments and feedback: jnl.info{at}oup.co.uk
Last modification:
Copyright© Oxford University Press, 1999.

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
S. Saran and P. Schaap
Adenylyl Cyclase G Is Activated by an Intramolecular Osmosensor
Mol. Biol. Cell, March 1, 2004; 15(3): 1479 - 1486.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. Gaudet, H. MacWilliams, and A. Tsang
Inducible expression of exogenous genes in Dictyostelium discoideum using the ribonucleotide reductase promoter
Nucleic Acids Res., January 15, 2001; 29(2): e5 - e5.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (300K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Gaudet, P.
Right arrow Articles by Tsang, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaudet, P.
Right arrow Articles by Tsang, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?